NDC 68462-188

Naproxen 250 mg tablet

On the label: Glenmark Pharmaceuticals Inc., USA.

Where it's made

Recalls

• Mar 13, 2025 · Class II · Glenmark Pharmaceuticals Inc., USA
  CGMP Deviations
  Lots: Lot # 17231956, exp. date Aug-25
• Nov 7, 2023 · Class II · Glenmark Pharmaceuticals Inc., USA
  Labeling: Label Mix-Up-Indomethacin bottles may be labeled as Naproxen
  Lots: Lot# 19231903; Exp 4/2025 Lot# 19231858; Exp 4/2025 Lot# 19231881; Exp 4/2025 Lot# 19233484: Exp 8/2025 Lot# 19233490; Exp 8/2025
• Aug 27, 2021 · Class II · Glenmark Pharmaceuticals Inc., USA
  CGMP Deviations
  Lots: Lots: 29190087 Exp. 10/31/2021; 29190088 Exp. 10/31/2021; 29190089 Exp. 10/31/2021; 29200077 Exp. 11/30/2022; 29200078 Exo, 11/30/2022
• Aug 27, 2021 · Class II · Glenmark Pharmaceuticals Inc., USA
  CGMP Deviations
  Lots: Lots: a) 29190082 Exp. 09/30/2021; 29190083 Exp. 09/30/2021; 29190084 Exp. 10/31/2021; 29190085 Exp. 10/31/2021; 29200001 Exp. 12/31/2021; 29200003 Exp. 01/31/2022; 29200004 Exp. 01/31/2022; 29200005 Exp. 01/31/2022; 29200012 Exp. 02/28/2022; 29200013 Exp. 02/28/2022; b) 29200010 Exp. 02/28/2022
• Jul 6, 2012 · Class II · Glenmark Generics Inc., USA
  Labeling: Label Mix-Up: Bottles labeled as Naproxen Tablets USP, 500 mg, 100-count may contain 90-count Pravastatin Sodium Tablets, 40 mg.
  Lots: Lot #: 02112930, 02112934, 02112941, Exp 09/14; 2112985, 02112986, 02113334, Exp 10/14; 02113360, 02113372, 02113420, 02113606, 02113663, 02113664, Exp 11/14.

Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.

Product details

Generic drug

Naproxen: every company that makes it

Form

tablet, oral

Strength

250 mg

Approval

ANDA ANDA078250

On the market since

Jul 1, 2007

Package NDCs

68462-188-01 68462-188-05

Official label

DailyMed (National Library of Medicine), updated Dec 23, 2025

Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?